HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Iseu da Silva Nunes Selected Research

P-mapa

12/2019P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study.
9/2016Potential therapeutic strategies for non - muscle invasive bladder cancer based on association of intravesical immunotherapy with p - mapa and systemic administration of cisplatin and doxorubicin.
1/2016Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Iseu da Silva Nunes Research Topics

Disease

2Neoplasms (Cancer)
12/2019 - 01/2016
2Non-Muscle Invasive Bladder Neoplasms
09/2016 - 01/2016
1Necrosis
12/2019
1Inflammation (Inflammations)
12/2019
1Ovarian Neoplasms (Ovarian Cancer)
12/2019

Drug/Important Bio-Agent (IBA)

3P-mapaIBA
12/2019 - 01/2016
2AnhydridesIBA
12/2019 - 09/2016
2Protein AggregatesIBA
12/2019 - 09/2016
2palmitoleic acidIBA
12/2019 - 09/2016
2MagnesiumIBA
12/2019 - 09/2016
2Toll-Like Receptors (Toll-Like Receptor)IBA
12/2019 - 01/2016
2Ammonium CompoundsIBA
12/2019 - 09/2016
1CytokinesIBA
12/2019
1Paclitaxel (Taxol)FDA LinkGeneric
12/2019
1Interleukin-12 (IL 12)IBA
12/2019
1ChemokinesIBA
12/2019
1Cisplatin (Platino)FDA LinkGeneric
09/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2016
1EndostatinsIBA
01/2016
1Immunologic Factors (Immunomodulators)IBA
01/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016
1InterferonsIBA
01/2016

Therapy/Procedure

3Immunotherapy
12/2019 - 01/2016
1Therapeutics
01/2016